Home > Publications database > Update on surveillance guidelines in emerging Wilms tumor predisposition syndromes. > print

001     294359
005     20250108101452.0
024 7 _ |a 10.1158/1078-0432.CCR-24-2488
|2 doi
024 7 _ |a pmid:39466169
|2 pmid
024 7 _ |a 1078-0432
|2 ISSN
024 7 _ |a 1557-3265
|2 ISSN
024 7 _ |a altmetric:169801208
|2 altmetric
037 _ _ |a DKFZ-2024-02192
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Brzezinski, Jack J
|0 0000-0002-9475-0077
|b 0
245 _ _ |a Update on surveillance guidelines in emerging Wilms tumor predisposition syndromes.
260 _ _ |a Philadelphia, Pa. [u.a.]
|c 2025
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736327665_15914
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Jan 6;31(1):18-24
520 _ _ |a Wilms tumors are commonly associated with predisposition syndromes. Many of these syndromes are associated with specific phenotypic features and are discussed in the related paper from the AACR Pediatric Cancer Working Group. Guidelines for surveillance in this population were published in 2017 but since then several studies have identified new genes with recurrent pathogenic variants associated with increased risk for Wilms tumor development. In general, variants in these genes are less likely to be associated with other phenotypic features. Recently, members of the AACR Pediatric Cancer Working Group met to update surveillance guidelines for patients with a predisposition to Wilms tumors with a review of recently published evidence and risk estimates. Risk estimates for Wilms tumor for the more recently described genes are discussed here along with suggested surveillance guidelines for these populations. Several other emerging clinical scenarios associated with Wilms tumor predisposition are also discussed including patients with family histories of Wilms tumor and no identified causative gene, patients with bilateral tumors, and patients with somatic mosaicism for chromosome 11p15.5 alterations. This perspective serves to update pediatric oncologists, geneticists, radiologists, counselors and other healthcare professionals on emerging evidence and harmonize updated surveillance recommendations in the North American and Australian context for patients with emerging forms of Wilms tumor predisposition.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Becktell, Kerri D
|0 0000-0002-1935-5157
|b 1
700 1 _ |a Bougeard, Gaëlle
|0 0000-0002-1475-0254
|b 2
700 1 _ |a Brodeur, Garrett M
|0 0000-0002-6721-122X
|b 3
700 1 _ |a Diller, Lisa R
|0 0000-0002-4073-5509
|b 4
700 1 _ |a Doria, Andrea S
|0 0000-0003-3202-0447
|b 5
700 1 _ |a Hansford, Jordan R
|0 0000-0001-7733-383X
|b 6
700 1 _ |a Kohlmann, Wendy K
|0 0000-0002-9134-9640
|b 7
700 1 _ |a Kratz, Christian P
|0 0000-0003-4120-5873
|b 8
700 1 _ |a MacFarland, Suzanne P
|0 0000-0001-5894-6403
|b 9
700 1 _ |a Pajtler, Kristian
|0 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
|b 10
|u dkfz
700 1 _ |a Rednam, Surya P
|0 0000-0001-8333-0758
|b 11
700 1 _ |a Schienda, Jaclyn
|0 0000-0003-2543-8378
|b 12
700 1 _ |a States, Lisa J
|0 0000-0003-0260-3975
|b 13
700 1 _ |a Villani, Anita
|0 0000-0003-3283-2197
|b 14
700 1 _ |a Weksberg, Rosanna
|0 0000-0002-6501-4150
|b 15
700 1 _ |a Zelley, Kristin
|0 0000-0003-0970-1850
|b 16
700 1 _ |a Tomlinson, Gail E
|0 0000-0003-2579-1833
|b 17
700 1 _ |a Kalish, Jennifer M
|0 0000-0003-1500-9713
|b 18
773 _ _ |a 10.1158/1078-0432.CCR-24-2488
|0 PERI:(DE-600)2036787-9
|n 1
|p 18-24
|t Clinical cancer research
|v 31
|y 2025
|x 1078-0432
909 C O |p VDB
|o oai:inrepo02.dkfz.de:294359
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN CANCER RES : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b CLIN CANCER RES : 2022
|d 2023-08-25
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21